Tivic Secures Barda Meeting for Entolimod(TM) for Acute Radiation Syndrome
Meeting with Radiological and Nuclear Medical Countermeasures Program FREMONT, CA / ACCESS Newswire / November 18, 2025 / Tivic Health®...
Staff
Day One to Participate in the Piper Sandler 37th Annual Healthcare Conference
BRISBANE, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals, Inc. (Nasdaq: DAWN) (“Day One” or the “Company”), a...
Avel eCare Specialty Clinic Surpasses 100,000 Patient Encounters, Expanding Access to Specialty Care Across Rural America
SIOUX FALLS, SD / ACCESS Newswire / November 18, 2025 / Avel eCare announced a landmark achievement this week as...
InStride Health Data Reveal 80% of Caregivers Report Reduction in Caregiver Strain among Families Navigating Youth Anxiety and OCD
Findings highlight how evidence-based approach that engages caregivers delivers measurable benefits beyond symptom reduction for the patientBOSTON, Nov. 18, 2025...
NetraMark Signs Four New Contracts With a Leading Global Pharmaceutical Company To Enhance Clinical Trial Insights
TORONTO, Nov. 18, 2025 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), a...
Moderna to Present at Upcoming Piper Sandler’s 37th Annual Healthcare Conference on December 2, 2025
CAMBRIDGE, MASSACHUSETTS / ACCESS Newswire / November 18, 2025 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following...
Crucial Innovations Corp. Appoints Rory Bowen to its Board of Directors
Seasoned finance and innovation executive brings global strategy and governance expertise to support CINV’s mission of advancing medicinal cannabis accessibility...
Bausch Health to Participate in the 8th Annual Evercore Healthcare Conference
LAVAL, QC / ACCESS Newswire / November 18, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), today announced that Jean-Jacques Charhon,...
OKYO Pharma to Present at OIS XV in San Diego
LONDON and NEW YORK, Nov. 18, 2025 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company which is...
Fennec Pharmaceuticals Announces Closing of Private Offering of Common Shares in Canada
RESEARCH TRIANGLE PARK, N.C., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC) (TSX:FRX) (“Fennec” or the “Company”), a...
TriageLogic Highlights the Growing Need for After-Hours Nurse Triage Services
After-hours service helps medical practices improve patient care and prevent unnecessary ER visits. JACKSONVILLE, FL / ACCESS Newswire / November...
Cuprina forms Joint Venture Company with Aiodine Laboratory to Develop and Market Novel Iodine-based Solution as New Wound Care Therapy
SINGAPORE, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (“Cuprina” or “the Company”), a biomedical company...
Autonomix Medical, Inc. Announces Pricing of $5.0 Million Private Placement Priced At The Market Under Nasdaq Rules
THE WOODLANDS, TX, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical...
CBD Life Sciences Inc. (CBDL) Secures Exclusive Launch of New Anti-Inflammatory “Soothe Gel” Across Two Red Hots Spa Locations in New York
With the global pain-management market projected to surpass $93.9 billion by 2030 and topical analgesics growing at a 7.2% CAGR,...
Radiopharm Theranostics Receives Approval to Initiate Phase 1 Therapeutic Trial of RAD 402 (KLK3-mAb with Tb161) in Advanced Prostate Cancer
RAD 402 is a humanized IgG1 internalized by prostate cells, binding KLK3 with high affinity Tb-161 antitumor activity driven by...
Catalyst Pharmaceuticals to Participate in Citi’s 2025 Global Healthcare Conference
CORAL GABLES, Fla., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical...
Mainz Biomed and OncoVanguard8 Enter into Agreement to bring ColoAlert to South America
OncoVanguard8 is a leading service provider for innovative healthcare products for insurance companies operating in Peru, Colombia and EcuadorBERKELEY, Calif....
Inspire Medical Systems, Inc. to Present at the Piper Sandler 37th Annual Healthcare Conference
MINNEAPOLIS, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on...
Entera Bio to Participate in the 8th Annual Evercore ISI Healthcare Conference
JERUSALEM, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (Nasdaq: ENTX), (“Entera” or the “Company”) a leader in the...
Nasus Pharma Announces Initiation of Phase 2 Clinical Study of NS002 with First Participant Dosed
The Phase 2 study is designed to address regulatory approval considerations by comparing bioavailability and pharmacokinetics of NS002 against EpiPen...